Linux Laboratories

24 products

Showing 1 - 24 of 24 products

Linux Laboratories – Innovating Neuropsychiatric and Critical Care Solutions

Linux Laboratories Pvt. Ltd., established in 2007 in Chennai, Tamil Nadu, is a dynamic pharmaceutical company dedicated to developing and delivering high-quality medications in the neuropsychiatric, critical care, and dermatology sectors. With a mission to make world-class medicines accessible and affordable, Linux Laboratories has rapidly ascended to become one of India's top 10 companies in the neuropsychiatry segment.

Therapeutic Specializations

Neuropsychiatry

Linux Laboratories has carved a niche in the Central Nervous System (CNS) domain, offering a comprehensive range of products addressing various mental health conditions. Their commitment to mental wellness is evident through continuous innovation and collaboration with healthcare professionals.

Critical Care

Recognizing the urgency and precision required in critical care, Linux Laboratories provides a robust portfolio of medications designed for emergency and intensive care scenarios. Their products are developed with a focus on rapid efficacy and safety.

Dermatology

Addressing a spectrum of skin conditions, Linux Laboratories offers dermatological solutions ranging from treatments for common ailments like acne and eczema to advanced therapies for more complex skin disorders. Their products are formulated to cater to diverse skin types and needs.

Divisional Structure

To streamline operations and focus on specialized therapeutic areas, Linux Laboratories has established distinct divisions:

Linux IMPERIA: The foundational division focusing on neuropsychiatric solutions.
Linux INFINA: A dynamic unit driving innovation in CNS treatments.
Linux INTEGRA: The latest addition, reinforcing the company's commitment to CNS leadership.

Global Presence and Partnerships

With a vision to extend its reach beyond Indian borders, Linux Laboratories launched its international business division in 2020. The company's commitment to quality and affordability has garnered trust in various global markets. In 2021, a significant milestone was achieved when Tata Capital invested in Linux Laboratories, underscoring the company's growth potential and industry standing.

Commitment to Quality and Innovation

Linux Laboratories' success is anchored in its unwavering commitment to quality, innovation, and patient-centricity. By continuously investing in research and development, the company ensures that its products meet the evolving needs of healthcare professionals and patients alike.